Furthermore, EEF1D overexpression cell lines should be constructed in future experiments to determine whether the overexpression of EEF1D increases Akt activation, and whether the PI3K/Akt inhibitors reverse the effect of EEF1D on increasing the resistance of ovarian cancer cells to cisplatin. The gene discussed is AKT1; the disease is ovarian cancer.